Compare FULC & LOCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FULC | LOCO |
|---|---|---|
| Founded | 2015 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 467.8M | 411.3M |
| IPO Year | 2019 | 2014 |
| Metric | FULC | LOCO |
|---|---|---|
| Price | $6.98 | $13.96 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 4 |
| Target Price | ★ $16.38 | $14.17 |
| AVG Volume (30 Days) | ★ 677.6K | 193.5K |
| Earning Date | 04-27-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.65 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $401,701,000.00 |
| Revenue This Year | N/A | $3.60 |
| Revenue Next Year | N/A | $3.98 |
| P/E Ratio | ★ N/A | $14.96 |
| Revenue Growth | N/A | ★ 5.68 |
| 52 Week Low | $5.47 | $8.87 |
| 52 Week High | $15.74 | $14.50 |
| Indicator | FULC | LOCO |
|---|---|---|
| Relative Strength Index (RSI) | 40.99 | 58.88 |
| Support Level | $6.39 | $13.42 |
| Resistance Level | $7.09 | $14.38 |
| Average True Range (ATR) | 0.47 | 0.44 |
| MACD | -0.06 | -0.05 |
| Stochastic Oscillator | 10.81 | 38.90 |
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing small molecules for genetically defined rare diseases. Its product candidate, Pociredir, is an oral small molecule designed to induce fetal hemoglobin (HbF) and is in clinical development for sickle cell disease (SCD). The company completed dosing in the Phase 1b PIONEER trial evaluating pociredir in adults with SCD and reported clinical data showing clinically relevant HbF induction and improvements in markers of hemolysis and anemia. The company has also generated a pipeline of clinical-stage and pre-clinical programs targeting the root causes of rare genetic diseases.
El Pollo Loco Holdings Inc operates and franchises hundreds of fast-casual chicken restaurants in the United States. It specializes in fire-grilling citrus-marinated chicken and operates in the limited service restaurant market segment. Its offerings include Mexican-inspired menu items, including burritos, tostadas, bowls, salads, and bone-in chicken meals in various portion sizes. It also offers citrus-marinated fire-grilled chicken, along with a range of salsas and dressings that allow customers to customize their meals. The company operates in one operating segment. The majority of the company's revenue is derived from company-operated restaurant revenue.